Clinical Trial

Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer Patients

Study acronym: INFLUENCE II
Recruiting
View on ClinicalTrials.gov →
Summary
This single-institution pilot study uses a pre- and post-implementation design to evaluate the implementation of ICG fluorescent imaging for sentinel lymph node biopsy (SLNB) in an Italian hospital.
Protocol Amendment History 1 change
minor Completion pushed: 2026-03 -> 2026-10 2026-05-12
Trial Details
NCT Number NCT07441733
Lead Sponsor Casa di Cura Dott. Pederzoli
Conditions Breast Cancer
Enrollment 40 participants
Start Date 2024-11-07
Primary Completion 2025-03-31 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-11